Journal
GASTROENTEROLOGY CLINICS OF NORTH AMERICA
Volume 42, Issue 1, Pages 187-+Publisher
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.gtc.2012.11.007
Keywords
Esophageal cancer; Treatment; Esophagectomy; Neoadjuvant; Chemoradiation; Adenocarcinoma; Squamous cell carcinoma
Categories
Ask authors/readers for more resources
The treatment of esophageal cancer has evolved considerably in the past decade and depends largely on the extent of disease at the time of presentation. For disease confined to the esophageal mucosa, endoscopic therapy is replacing esophagectomy as the standard of care. For locoregional disease, neoadjuvant chemoradiation followed by esophagectomy is the best strategy for optimizing long-term survival. In the minority of patents who present with metastatic disease, the prognosis is poor. Palliative therapies available for these patients include chemotherapy, radiation, endoscopic therapies to ameliorate obstruction or bleeding, and surgical intervention to optimize nutritional status or to relieve obstruction.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available